Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
DDev PlastiksQ1 FY27Chemicals & Petrochemicals
Home/Stocks/DDev Plastiks/Q1 FY27

DDev Plastiks Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹276P/E: 13.5Market Cap: ₹2.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • →Target volume growth of approximately 15% in FY27, aiming to grow faster than the cable customer segment's 12-13% growth rate by gaining market share domestically and in exports.
  • →FY27 revenue growth guidance is conservative at around 13%, based largely on volume growth, with no assumed price increases.
  • →New capacity at Bhiwadi expected to ramp up gradually, targeting ~50% average utilization in FY27, increasing volumes especially in the second half.
  • →Focus on better product and geographical mix to improve margins, with per ton realization improving by about INR200 each quarter recently.
  • →Expects utilization levels around 70% by year-end with a tonnage run rate of about 231,000 tons for the year.
  • →BESS project capacity starts with 1 GWh, capex of INR200 crore, aiming to generate INR900 crore turnover at full capacity around mid-FY29.
  • →Export volumes expected to grow with shifting capacities; cautious about short-term market volatility impacting growth.

Margin guidance

Category 3
  • →Ddev Plastiks projects a volume growth of approximately 15% in FY27, driven by ramp-up of new capacity and market share gains.
  • →EBITDA per ton is expected to remain in the range of INR15 to INR17 (excluding volatility premiums), targeting a sustainable EBITDA margin of 10-12%.
  • →The company aims to improve product and geographic mix, contributing to better margin profiles quarterly by INR200 per ton.
  • →Capacity utilization for FY27 expected around 50-70%, with new units (e.g., Bhiwadi) gradually ramping up.
  • →FY27 revenue growth guided conservatively at 13%, considering stable prices averaging last fiscal year levels.
  • →BESS business expected to contribute EBITDA margins of 6-8% initially, with potential to scale up margins to ~13% over time through EPC and system integration.
  • →Uncertainties such as raw material prices and geopolitical factors may impact near-term profitability visibility, but long-term growth and margin improvement are targeted.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes
  • →Currently, the company is funding the first phase of its BESS business (INR 200 crore capex) entirely from internal accruals.
  • →For the initial phase, management does not expect significant debt increase; internal accruals will be primarily used.
  • →However, for future phases or scaling up, external funding needs may arise but specifics are yet to be determined.
  • →The management is open to exploring new opportunities, including joint ventures or investments for backward integration, implying possible future funding activities.
  • →There is no explicit mention of planned equity fundraising at this stage.
  • →Overall, near-term focus is on utilizing internal resources with flexibility to consider external funding if warranted by opportunities.

Order book

  • →The company's order book is generally spot-based, with orders not extending beyond 10 to 15 days, possibly up to 20 days.
  • →As of the call, visibility on order books is limited; they can only comment reliably up to August 2026.
  • →Export and domestic market uncertainties, including geopolitical issues like the situation with Iran, add to this limited visibility.
  • →Despite this, July 2026 was a comparatively good month, and August 2026 appears stable so far.
  • →New capacities are just ramping up, and while Q1 volume growth was low (~1%), a 15% volume growth target for FY27 is maintained.
  • →The company expects to ramp up new plant utilization in the second half, aiding order execution.
  • →Retendering and delayed projects due to pricing issues might lead to future opportunities.

Capex plans

Yes
  • →The company has committed capex of INR150-175 crores for the year, including new capacities for HFFR and medium voltage cables in the East (near Vapi) and investments in BESS business.
  • →The new site at Vapi aims to consolidate products from multiple plants and expand space for capacity addition.
  • →Bhiwadi facility with 48,000 tons capacity was recently added; expected to ramp up utilization progressively, targeting INR500 crore incremental revenue.
  • →For the BESS (Battery Energy Storage System) business, an initial capex of around INR200 crores is planned for a 1 gigawatt hour facility, expected operational by mid-FY29; funded primarily through internal accruals with potential additional working capital debt of INR100-150 crores.
  • →The company is open to backward integration, joint ventures, and new investment opportunities as and when they arise.
  • →Expansion into Eastern India with warehouse and manufacturing capacity is underway following a strategic shift.

How does DDev Plastiks rank vs peers in Chemicals & Petrochemicals?

Pro feature
1DDev Plastiks
Rev 3Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does DDev Plastiks rank in Chemicals & Petrochemicals?

Compare DDev Plastiks against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — DDev Plastiks

Other quarters — DDev Plastiks

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
DDev Plastiks full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What DDev Plastiks's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF